Cargando…
Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting
Despite the availability of various anticancer agents, Multiple Myeloma (MM) remains incurable in most cases, along with high relapse rate in the patients treated with these agents. The year 2015 saw major advancements in our battle against multiple myeloma. In 2015, the U.S. Food and Drug Administr...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354697/ https://www.ncbi.nlm.nih.gov/pubmed/27863374 http://dx.doi.org/10.18632/oncotarget.13314 |